News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,289 Results
Type
Article (14257)
Company Profile (281)
Press Release (253751)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79576)
Career Advice (152)
Deals (13241)
Drug Delivery (35)
Drug Development (50463)
Employer Resources (31)
FDA (5728)
Job Trends (5136)
News (144495)
Policy (10036)
Tag
Academia (916)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (21683)
ALS (64)
Alzheimer's disease (848)
Antibody-drug conjugate (ADC) (100)
Approvals (5755)
Artificial intelligence (125)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4561)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (232)
Bladder cancer (59)
Brain cancer (20)
Breast cancer (155)
Cancer (1485)
Cardiovascular disease (117)
Career advice (133)
Career pathing (2)
CAR-T (118)
Cell therapy (333)
Cervical cancer (8)
Clinical research (41094)
Collaboration (542)
Compensation (263)
Complete response letters (13)
COVID-19 (1034)
CRISPR (42)
C-suite (165)
Cystic fibrosis (76)
Data (1531)
Denatured (11)
Depression (31)
Diabetes (139)
Diagnostics (1302)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (29873)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48645)
Executive appointments (464)
FDA (6435)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (498)
Gene editing (97)
Generative AI (10)
Gene therapy (255)
GLP-1 (367)
Government (1082)
Grass and pollen (2)
Guidances (27)
Healthcare (6596)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (92)
Indications (20)
Infectious disease (1099)
Inflammatory bowel disease (115)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (67)
Interviews (17)
IPO (7282)
IRA (11)
Job creations (861)
Job search strategy (127)
Kidney cancer (7)
Labor market (5)
Layoffs (211)
Leadership (3)
Legal (1387)
Liver cancer (33)
Lung cancer (205)
Lymphoma (102)
Machine learning (3)
Management (7)
Manufacturing (140)
MASH (54)
Medical device (2608)
Medtech (2609)
Mergers & acquisitions (6291)
Metabolic disorders (391)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (25)
Neuroscience (1260)
NextGen: Class of 2025 (2018)
Non-profit (852)
Now hiring (21)
Obesity (194)
Opinion (102)
Ovarian cancer (63)
Pain (44)
Pancreatic cancer (56)
Parkinson's disease (121)
Partnered (8)
Patents (130)
Patient recruitment (79)
Peanut (35)
People (25674)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14518)
Phase II (19114)
Phase III (12082)
Pipeline (818)
Policy (46)
Postmarket research (852)
Preclinical (6141)
Press Release (30)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (292)
Real estate (1420)
Recruiting (12)
Regulatory (8651)
Reports (15)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (61)
Series A (98)
Series B (63)
Service/supplier (1)
Sickle cell disease (40)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1975)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (9)
The Weekly (36)
Vaccines (215)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Last 7 days (520)
Last 30 days (1440)
Last 365 days (19449)
2025 (6368)
2024 (20552)
2023 (22420)
2022 (26827)
2021 (27810)
2020 (23362)
2019 (16256)
2018 (11755)
2017 (13749)
2016 (11841)
2015 (14352)
2014 (10394)
2013 (7485)
2012 (7534)
2011 (7617)
2010 (7430)
Location
Africa (149)
Alabama (42)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17320)
Australia (2935)
California (3889)
Canada (1145)
China (361)
Colorado (149)
Connecticut (152)
Delaware (103)
Europe (37260)
Florida (468)
Georgia (117)
Idaho (16)
Illinois (234)
India (10)
Indiana (92)
Iowa (2)
Japan (75)
Kansas (62)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (478)
Massachusetts (3095)
Michigan (70)
Minnesota (148)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (971)
New Mexico (12)
New York (1050)
North Carolina (556)
North Dakota (5)
Northern California (1716)
Ohio (112)
Oklahoma (9)
Oregon (21)
Pennsylvania (743)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (4)
Southern California (1498)
Tennessee (25)
Texas (450)
United States (13339)
Utah (53)
Virginia (80)
Washington D.C. (30)
Washington State (352)
Wisconsin (15)
268,289 Results for "envoy therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Envoy Medical Reports on First Quarter 2025 Results
Company Provides Update on Its Pivotal Clinical Study for Fully Implanted Cochlear Implant
May 1, 2025
·
13 min read
Press Releases
Envoy Medical to Participate in the 37th Annual ROTH Conference
March 10, 2025
·
6 min read
Press Releases
Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results
Company Provides Corporate Update that Includes Information on its Progress Enrolling Subjects in its Pivotal Clinical Study for Breakthrough Device, the Fully Implanted Acclaim® Cochlear Implant
March 31, 2025
·
15 min read
Press Releases
Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio
February 14, 2025
·
8 min read
Press Releases
Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device
Billionaire Entrepreneur Glen Taylor, the Company’s Largest Shareholder, Continues to Invest Significant Capital into the Company Furthering Its Progress
March 12, 2025
·
6 min read
Press Releases
Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study
Initial patient enrollment anticipated during first quarter of 2025
December 19, 2024
·
8 min read
Deals
Envoy Medical Announces Shareholder Approval on Proposed Merger with Anzu Special Acquisition Corp I
Envoy Medical® Corporation (“Envoy”), a hearing health company, today announced that the proposed merger with Anzu Special Acquisition Corp I
September 28, 2023
·
10 min read
BioMidwest
Breakthrough Hearing Health Technology Firm, Envoy Medical Begins Trading On NASDAQ
Envoy Medical to Begin Trading October 2nd on NASDAQ with Ticker COCH
October 2, 2023
·
7 min read
Business
Envoy Medical Announces Proposed Board Slate of Experienced Medical Device and Financial Leaders
Envoy Medical® Corporation (“Envoy”), a hearing health company, today announced the proposed slate of seven directors to be voted on during the special meeting of stockholders to be held by its merger partner
September 19, 2023
·
15 min read
Deals
MCRA Provides Anzu Special Acquisition Corp I with Strategic Diligence Support Leading to Envoy Medical Merger (NASDAQ: COCH)
MCRA, LLC is pleased to announce its role in providing strategic due diligence support for Anzu Special Acquisition Corp I, ahead of the recent deal with Envoy Medical .
January 22, 2024
·
5 min read
1 of 26,829
Next
